These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2487172)

  • 21. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G; Jones BD
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion.
    Apicella P; Legallet E; Nieoullon A; Trouche E
    Behav Brain Res; 1991 Dec; 46(2):187-95. PubMed ID: 1786125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right hemispatial inattention and magical ideation.
    Brugger P; Graves RE
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(1):55-7. PubMed ID: 9088807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
    Howes OD; McCutcheon R; Owen MJ; Murray RM
    Biol Psychiatry; 2017 Jan; 81(1):9-20. PubMed ID: 27720198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between striatal reduction and poor Wisconsin card sorting test performance in patients with schizophrenia.
    Stratta P; Mancini F; Mattei P; Daneluzzo E; Casacchia M; Rossi A
    Biol Psychiatry; 1997 Nov; 42(9):816-20. PubMed ID: 9347130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bereitschaftspotential in tardive dyskinesia.
    Adler LE; Pecevich M; Nagamoto H
    Mov Disord; 1989; 4(2):105-12. PubMed ID: 2733704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
    Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
    Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.
    Pickar D; Litman RE; Konicki PE; Wolkowitz OM; Breier A
    Mod Probl Pharmacopsychiatry; 1990; 24():124-51. PubMed ID: 1970851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lateralization of striatal dopamine (D2) receptors in normal rats.
    Schneider LH; Murphy RB; Coons EE
    Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathway-Specific Dopamine Abnormalities in Schizophrenia.
    Weinstein JJ; Chohan MO; Slifstein M; Kegeles LS; Moore H; Abi-Dargham A
    Biol Psychiatry; 2017 Jan; 81(1):31-42. PubMed ID: 27206569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.
    Chuhma N; Mingote S; Kalmbach A; Yetnikoff L; Rayport S
    Biol Psychiatry; 2017 Jan; 81(1):43-51. PubMed ID: 27692238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation.
    Herrera-Marschitz M; Utsumi H; Ungerstedt U
    J Neurol Neurosurg Psychiatry; 1990 Jan; 53(1):39-43. PubMed ID: 2303830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The coincidence of schizophrenia and Parkinsonism: some neurochemical implications.
    Crow TJ; Johnstone EC; McClelleand HA
    Psychol Med; 1976 May; 6(2):227-33. PubMed ID: 1005563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dopamine hypothesis of schizophrenia: version III--the final common pathway.
    Howes OD; Kapur S
    Schizophr Bull; 2009 May; 35(3):549-62. PubMed ID: 19325164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal D(2) dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study.
    Syvälahti EK; Räkköläinen V; Aaltonen J; Lehtinen V; Hietala J
    Schizophr Res; 2000 Jun; 43(2-3):159-61. PubMed ID: 10858634
    [No Abstract]   [Full Text] [Related]  

  • 39. Unilateral frontal cortex ablation producing neglect causes time-dependent changes in striatal glutamate receptors.
    Vargo JM; Marshall JF
    Behav Brain Res; 1996 May; 77(1-2):189-99. PubMed ID: 8762170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal dopamine and the interface between orienting and ingestive functions.
    Hall S; Schallert T
    Physiol Behav; 1988; 44(4-5):469-71. PubMed ID: 3237839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.